NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · IEX Real-Time Price · USD
2.330
0.00 (0.00%)
At close: Jul 19, 2024, 4:00 PM
2.390
+0.060 (2.58%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
NRx Pharmaceuticals Market Cap
NRx Pharmaceuticals has a market cap or net worth of $24.93 million as of July 22, 2024. Its market cap has decreased by -24.68% in one year.
Market Cap
24.93M
Enterprise Value
30.39M
1-Year Change
-24.68%
Ranking
Category
Stock Price
$2.33
Market Cap Chart
Since November 20, 2017, NRx Pharmaceuticals's market cap has decreased from $65.80M to $24.93M, a decrease of -62.11%. That is a compound annual growth rate of -13.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 24.90M | -35.49% |
| Dec 29, 2023 | 38.60M | -48.60% |
| Dec 30, 2022 | 75.10M | -73.28% |
| Dec 31, 2021 | 281.10M | 328.51% |
| Dec 31, 2020 | 65.60M | 2.02% |
| Dec 31, 2019 | 64.30M | -30.26% |
| Dec 31, 2018 | 92.20M | 44.97% |
| Dec 29, 2017 | 63.60M | -3.34% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAB Biotherapeutics | 26.21M |
| Beyond Air | 26.06M |
| ATI Physical Therapy | 25.89M |
| NeuroBo Pharmaceuticals | 25.57M |
| NanoViricides | 25.05M |
| Accelerate Diagnostics | 24.70M |
| Meihua International Medical Technologies Co. | 24.44M |
| Trinity Biotech | 24.42M |